Evaluating factors that predict outcomes in patients with acute subdural hematoma
A Comparative Analysis of Prognostic Factors for Functional Outcomes in Patients With Acute Subdural Hematoma
This study is testing how well current scoring systems can predict recovery and survival in patients of different ages who have had surgery for acute subdural hematoma.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Charles University, Czech Republic Academic / other |
| Locations | 1 site (Praha) |
| Trial ID | NCT06364059 on ClinicalTrials.gov |
What this trial studies
This study focuses on patients with acute subdural hematoma (ASDH), a common type of brain injury requiring surgery. It aims to assess the effectiveness of current scoring systems in predicting functional outcomes across different age groups. By analyzing various clinical and radiologic factors, the research seeks to clarify the relationship between these factors and both mortality risk and functional recovery. The study will follow patients for 12 months post-surgery, measuring outcomes using the Glasgow Outcome Scale Extended.
Who should consider this trial
Good fit: Ideal candidates are patients who have undergone surgery for acute subdural hematoma and can commit to a 12-month follow-up.
Not a fit: Patients who do not undergo surgery for acute subdural hematoma may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve prognostic accuracy and treatment strategies for patients with acute subdural hematoma.
How similar studies have performed: While there is existing research on acute subdural hematoma, this study's specific focus on contemporary scoring systems across age groups is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * surgery due to ASDH * 12 months of follow-up * functional outcome measured by the Glasgow Outcome Scale Extended (GOSE). Exclusion Criteria: * none
Where this trial is running
Praha
- Military University Hospital Prague — Praha, Czechia (Recruiting)
Study contacts
- Study coordinator: Ilona Trtíková, Mgr., Ph.D.
- Email: Ilona.Trtikova@lf1.cuni.cz
- Phone: +420 224 96 5602
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.